Sachdev Amit

In July 2026, Vertex Pharmaceuticals Inc executive Amit Sachdev received a restricted stock award (Code A) of 8,251 shares. Zooming out across his 443 lifetime Form 4 filings reveals a highly structured annual executive compensation rhythm: equity awards in July and February paired with automated Code F tax withholdings at market valuations exceeding $460 to $483 per share. On February 17, 2026, Sachdev received 5,789 award shares alongside an automated Code F tax withholding of 2,140 shares at $483.75 ($1.04 million value). This mirrored February 2025 vesting events where 3,703 shares were withheld at $479.61 ($1.78 million) and 2,470 shares were withheld at $483.28 ($1.19 million). Across 435 Vertex filings, cumulative disposed shares reach 1,069,711.